Alimera Sciences Inc.

(ALIM) Trade

By |

Profile

Alimera Sciences Inc is a pharmaceutical company. It specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. The product portfolio of the company includes ILUVIEN, which is developed to treat diabetic macular edema. In addition, to the activities related to the development of ILUVIEN, the group is also researching the safety and effectiveness of NADPH (Nicotinamide Adenine Dinucleotide Phosphate) oxidase inhibitors. Geographically it operates through the region of US and also it has its presence in the international market.

Contact Information

Website: www.alimerasciences.com
Email: John.Mills@ICRINC.com
Main Phone: +1 678 990-5740
Address: 6120 Windward Parkway
Address 2: Suite 290
State: GA
City / Town: Alpharetta
Country: USA
Postal Code: 30005

Issuer Information

Exchange: NSD
CEO: C. Daniel Myers
Employees: 126
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.91 $ -0.03 (-3.19%)
Last Price 0.91 Change $ -0.03 Change % -3.19 Tick N/A
Bid 0.88 Bid Size 100.00 Ask 1.15 Ask Size 5,000.00
Open 0.98 High 0.98 Low 0.91 Prev Close 0.94
Last Trade Volume 49,480 52 Wk Hi 1.38 52 Wk Low 0.74
Market Cap 63.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 70,078,878.00 EPS (TTM) 0.11 PE Ratio 8.90 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 26
Number of Buys 1 6
Number of Sells 0 20
Net Activity 10000 133969
Last 10 Buys Shares
Richard S. Eiswirth 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Flynn E James 1,000
Last 10 Sell Shares
David Holland 1,000
Philip Ashman 1,000
Kenneth Green 1,000
C. Daniel Myers 1,000
Richard S. Eiswirth 1,000
David Holland 1,000
Kenneth Green 1,000
C. Daniel Myers 1,000
Philip Ashman 1,000
Richard S. Eiswirth 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 2.5 2.5 2.5 2.5
Mean Target Price Estimate 2.75 2.75 2.75 2.75
Standard Deviation 0.35 0.35 0.35 0.35
Date of Most Recent Estimate 05/08/18 05/08/18 05/08/18 05/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1